Sarcoma  >>  Ayvakit (avapritinib)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ayvakit (avapritinib) / Blueprint Medicines
VOYAGER, NCT03465722 / 2017-003497-14: () Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Completed
3
476
Europe, Canada, US, RoW
avapritinib, BLU-285, regorafenib, Stivarga
Blueprint Medicines Corporation
GIST
03/20
09/21

Download Options